BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16388927)

  • 1. Determination of metabolic stability of positron emission tomography tracers by LC-MS/MS: an example in WAY-100635 and two analogues.
    Lavén M; Itsenko O; Markides K; Långström B
    J Pharm Biomed Anal; 2006 Mar; 40(4):943-51. PubMed ID: 16388927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of microsomal metabolic stability using high-flow-rate extraction coupled to capillary liquid chromatography-mass spectrometry.
    Lavén M; Markides K; Långström B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):119-26. PubMed ID: 15171920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in metabolites of PET ligands: serotonergic 5-HT1A receptor antagonists 3-trans-FCWAY and 3-cis-FCWAY.
    Ma Y; Lang L; Kiesewetter D; Jagoda E; Eckelman WC
    Nucl Med Biol; 2006 Nov; 33(8):1013-9. PubMed ID: 17127175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 and radiopharmaceutical metabolism.
    Giron MC; Portolan S; Bin A; Mazzi U; Cutler CS
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):254-66. PubMed ID: 18475251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography-tandem mass spectrometry identification of metabolites of two 5-HT1A antagonists, N-[2-[4-(2-methoxylphenyl)piperazino]ethyl]-N-(2-pyridyl) trans- and cis-4-fluorocyclohexanecarboxamide, produced by human and rat hepatocytes.
    Ma Y; Lang L; Kiesewetter DO; Jagoda E; Sassaman MB; Der M; Eckelman WC
    J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):47-56. PubMed ID: 11393732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validated LC-MS-MS method for determination of m-nisoldipine polymorphs in rat plasma and its application to pharmacokinetic studies.
    Wang H; Zhang L; Wang Q; Yuan Z; Li M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):71-6. PubMed ID: 16567136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective σ1 receptor binding and biotransformation of the spirocyclic PET tracer 1'-benzyl-3-(3-fluoropropyl)-3H-spiro[[2]benzofuran-1,4'-piperidine].
    Wiese C; Grosse Maestrup E; Schepmann D; Grimme S; Humpf HU; Brust P; Wünsch B
    Chirality; 2011 Feb; 23(2):148-54. PubMed ID: 20845431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of a 14C/3H-labeled GABAA receptor partial agonist in rat, dog and human liver microsomes: evaluation of a dual-radiolabel strategy.
    Shaffer CL; Langer CS
    J Pharm Biomed Anal; 2007 Mar; 43(4):1195-205. PubMed ID: 17150324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of capsaicin, a transient receptor potential channel vanilloid 1 agonist, by liquid chromatography quadrupole ion trap mass spectrometry: evaluation of in vitro metabolic stability.
    Beaudry F; Vachon P
    Biomed Chromatogr; 2009 Feb; 23(2):204-11. PubMed ID: 18816461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) in rodents and humans.
    Bier D; Holschbach MH; Wutz W; Olsson RA; Coenen HH
    Drug Metab Dispos; 2006 Apr; 34(4):570-6. PubMed ID: 16415116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the in vitro metabolism of fipexide: characterization of reactive metabolites using liquid chromatography/mass spectrometry.
    Sleno L; Staack RF; Varesio E; Hopfgartner G
    Rapid Commun Mass Spectrom; 2007; 21(14):2301-11. PubMed ID: 17577876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivatives of WAY 100635 as potential imaging agents for 5-HT1A receptors: syntheses, radiosyntheses, and in vitro and in vivo evaluation.
    Wilson AA; Inaba T; Fischer N; Dixon LM; Nobrega J; DaSilva JN; Houle S
    Nucl Med Biol; 1998 Nov; 25(8):769-76. PubMed ID: 9863565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
    Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
    J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A liquid chromatography-mass spectrometry assay for simultaneous determination of two antimalarial thiazolium compounds in human and rat matrices.
    Taudon N; Margout D; Calas M; Kezutyte T; Vial HJ; Bressolle FM
    J Pharm Biomed Anal; 2008 Nov; 48(3):1001-5. PubMed ID: 18678456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography-mass spectrometry.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2009 Oct; 50(3):475-90. PubMed ID: 19535209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrafast LC method for purification and metabolite analysis of PET probes.
    Nakao R; Ito T; Hayashi K; Fukumura T; Suzuki K
    Nucl Med Biol; 2010 Jan; 37(1):67-72. PubMed ID: 20122670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 96-well single-pot protein precipitation, liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of muraglitazar, a novel diabetes drug, in human plasma.
    Xue YJ; Liu J; Pursley J; Unger S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):213-22. PubMed ID: 16388995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a liquid chromatographic/mass spectrometry method for quantification of tetrandrine in rat plasma and its application to pharmacokinetic study.
    Song N; Zhang S; Li Q; Liu C
    J Pharm Biomed Anal; 2008 Nov; 48(3):974-9. PubMed ID: 18650047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of metabolites of a novel histamine H(2)-receptor antagonist, lafutidine, in human liver microsomes by liquid chromatography coupled with ion trap mass spectrometry.
    Wang Y; Chen X; Li Q; Zhong D
    Rapid Commun Mass Spectrom; 2008 Jun; 22(12):1843-52. PubMed ID: 18470870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates.
    Di L; Kerns EH; Hong Y; Kleintop TA; McConnell OJ; Huryn DM
    J Biomol Screen; 2003 Aug; 8(4):453-62. PubMed ID: 14567798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.